Css LLC Heron Therapeutics, Inc. Call Options Transaction History

Css LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	BUY	$2.3 - $6.29 $88,320 - $241,536	38,400 Added 492.31%	46,200 $129,000
Q1 2022 May 16, 2022	SELL	$4.63 - $9.94 $56,486 - $121,268	-12,200 Reduced 61.0%	7,800 $45,000
Q3 2021 Nov 15, 2021	SELL	$10.13 - $15.0 $395,070 - $585,000	-39,000 Reduced 66.1%	20,000 $214,000
Q1 2021 May 17, 2021	BUY	$14.49 - $20.72 $854,910 - $1.22 Million	59,000 New	59,000 $956,000
Q3 2020 Nov 16, 2020	SELL	$13.67 - $17.77 $2,734 - $3,554	-200 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$10.89 - $21.47 $2,178 - $4,294	200 New	200 $3,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $188M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.